14Feb
13Feb
Hoth Therapeutics Announces Positive Preliminary, Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease
The study conducted in partnership with Zylö Therapeutics confirmed AEA-loaded in Z-pods™ provides an actual reduction in lesion score. Read more >>
13Feb
Pixability Releases Competitive Insights Tool For YouTube
The agency is testing a tool called BrandTrack to analyze and benchmark brand activity by vertical on YouTube. The tool, from brand safety vendor Pixability, came out of beta on Wednesday and is available as an SaaS offering or as part of Pixability’s core video ad software platform. Read more >>
13Feb
eSight Corporation Announces New President and CEO
eSight Corporation, a leading vision enhancing platform, is pleased to announce the appointment of Robert Vaters as President and CEO effective February 3rd. Read more >>
12Feb
Being an Underdog with Laurel Taylor
Underdog stories are everywhere — in film, TV, the news, and all manner of books. They are classic heroic tales about the ones no one bet on (and many bet against) coming out on top. Laurel Taylor is the Founder and CEO of FutureFuel.io. She learned to embrace being underestimated and treated that rejection as a catalyst for something more. Read more >>
12Feb
Advancing Platelet-Based Therapeutics for Patients
Platelet BioGenesis (PBG) reports that it is working with the Canadian Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare Life Sciences to develop customized media formulations that will enable efficient differentiation of stem cells to platelet-based treatments, thereby avoiding the reliance on blood donors in the future. Read more >>
07Feb
Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it plans to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Corbus. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of...
31Jan
New project to advance platelet-based therapeutics for patients
There is a chronic global shortage of platelets to treat patients who are actively bleeding due to trauma or surgery, those undergoing treatments for cancer, or those with low platelet counts due to a variety of conditions – essentially anyone who needs to prevent life-threatening bleeding. Platelet BioGenesis (PBG) is working with CCRM and GE Healthcare Life Sciences to develop customized media formulations that will enable efficient differentiation of stem cells to platelet-based therapeutics, thereby avoiding the reliance on blood...
31Jan
Aircuity Celebrates 20 Years – Company celebrates the impact made on the environment
Aircuity announced that 2020 marks the company’s 20-year anniversary. “Our founder, Gordon Sharp, is truly an industry pioneer and was ahead of his time when creating Aircuity in 2000,” said Aircuity CEO, Dan Diehl. “We thank our progressive and demanding clients who believed in Aircuity early on and who have helped us continually evolve and improve.”Read more >>"
30Jan